The French Institute in Serbia is once again organising the event “France on the Move,” featuring performances in the field ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...
Hyderabad: Dr Reddy’s Laboratories Ltd., is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride ...
Dr. Reddys Laboratories is recalling a batch of Levetiracetam injection bags in the U.S. due to incorrect labeling, which ...
By blocking dopamine-1 receptors, ecopipam is expected to reduce the repetitive and compulsive behaviors seen in Tourette syndrome.
Dr Reddy’s Laboratories is recalling one batch of Levetiracetam in 0.75 percent Sodium Chloride Injection single-dose ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...
Dr. Reddy's recalls Levetiracetam infusion bags in the U.S. due to mislabeling, posing risk of serious adverse effects.
A new study followed female participants with an average age of 83 who did not have mild cognitive impairment or dementia at ...
Dr. Reddy’s Laboratories has initiated a voluntary recall of Levetiracetam in 0.75% Sodium Chloride Injection (1,000 mg/100 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback